BridgeMD
New treatment option for Hip Fractures
Official title Optimized Rehabilitation of Older Adults With Hip Fracture and Signs of Cognitive Impairment - Feasibility Study
ClinicalTrials.gov ID: NCT06286722
What this study is testing
- What it's testing
- Older adults suffering from a hip fracture are a significant concern, with higher incidence rates among women. Mortality rates post-hip fracture are alarming, with up to 8-fold increased risk within 3 months and significant percentages within 30 days and 12 months.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Recently (within 3 weeks) underwent surgical repair of a hip fracture (femoral neck or trochanteric fracture)
- Independent pre-fracture ambulatory function (≥2 on the New Mobility Score on indoor walking)
- Having signs of cognitive impairment measured with the Mini-Mental Score Examination of \<24 points, or a verified dementia diagnosis, or on...
- Living in their own home, nursing home, or assisted living facilities
- Informed consent by patient
You likely can't join if
- Pathological hip fracture
- Having signs of severe dementia measured with the Mini-Mental State Examination (\<10 points)
- Non-Danish speaking
- Patients with an unstable health condition (e.g. not treated high blood pressure (\>180 mm HG)) evaluated by medical consultant
- "Safety concerns" (e.g. underlying comorbidities that might be associated with serious adverse events) - not safe to participate in the opinion of...
- Having behavioral or psychotic disorders
See the full eligibility criteria
- Recently (within 3 weeks) underwent surgical repair of a hip fracture (femoral neck or trochanteric fracture)
- Independent pre-fracture ambulatory function (≥2 on the New Mobility Score on indoor walking)
- Having signs of cognitive impairment measured with the Mini-Mental Score Examination of \<24 points, or a verified dementia diagnosis, or on information from the patient record
- Living in their own home, nursing home, or assisted living facilities
- Informed consent by patient
- Pathological hip fracture
- Having signs of severe dementia measured with the Mini-Mental State Examination (\<10 points)
- Non-Danish speaking
- Patients with an unstable health condition (e.g. not treated high blood pressure (\>180 mm HG)) evaluated by medical consultant
- "Safety concerns" (e.g. underlying comorbidities that might be associated with serious adverse events) - not safe to participate in the opinion of the investigator
- Having behavioral or psychotic disorders
- Alcohol or drug abuse
- Unable to participate in the intervention (e.g. due to blindness, no language)
- Patients with any weight-bearing restrictions after surgery
The study team makes the final eligibility decision.
Where it's taking place
- Frederiksberg, Denmark
- Hårlev, Denmark
- Hørsholm, Denmark
- Maribo, Denmark
- Nykøbing Falster, Denmark
- Vordingborg, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Frederiksberg, Denmark; Hårlev, Denmark; Hørsholm, Denmark; Maribo, Denmark; Nykøbing Falster, Denmark; Vordingborg, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.